115 STAT. 14 PUBLIC LAW 107-9 —MAY 24, 2001 Deadline. (C) the Subcommittee on Agriculture, Rural Development, and Related Agencies of the Committee on Appropriations of the Senate; and (D) the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies of the Committee on Appropriations of the House of Representatives. (b) FINAL REPORT.— (1) IN GENERAL.— Not later than 180 days after the date of enactment of this Act, the Secretary of Agriculture shall submit to the committees and subcommittees described in subsection (a)(2) a final report that— (A) discusses the economic impacts associated with the potential introduction of foot-and-mouth disease, bovine spongiform encephalopathy, and related diseases into the United States; (B) discusses the potential risks to public and animal health from foot-and-mouth disease, bovine spongiform encephalopathy, and related diseases; and (C) provides recommendations to protect the health of animal herds and citizens of the United States from those risks including, if necessary, recommendations for additional legislation, appropriations, or product bans. (2) CONTENTS. —The report shall contain— (A) an assessment of the risks to the public presented by the potential presence of foot-and-mouth disease, bovine spongiform encephalopathy, and related diseases in domestic and imported livestock, livestock and animal products, wildlife, and blood products; (B) recommendations to reduce and manage the risks of foot-and-mouth disease, bovine spongiform encephalopathy, and related diseases; (C) any plans of the Secretary to identify, prevent, and control foot-and-mouth disease, bovine spongiform encephalopathy, and related diseases in domestic and imported livestock, livestock products, wildlife, and blood products; (D) a description of the incidence and prevalence of foot-and-mouth disease, bovine spongiform encephalopathy, variant Creutzfeldt-Jacob disease, and related diseases in other countries; (E) a description and an analysis of the effectiveness of the measures, taken to assess, prevent, and control the risks of foot-and-mouth disease, bovine spongiform encephalopathy, variant Creutzfeldt-Jacob disease, and related diseases in other countries; (F) a description and an analysis of the effectiveness of the measures that the public, private, and nonprofit sectors have taken to assess, prevent, and control the risk of foot-and-mouth disease, bovine spongiform encephalopathy, and related diseases in the United States, including controls of ports of entry and other conveyances; (G) a description of the measures taken to prevent and control the risk of bovine spongiform encephalopathy and variant Creutzfeldt-Jacob disease trsmsmission through blood collection and transfusion;
�
